A daily probiotic supplement may enhance treatment outcomes for older adults diagnosed with moderate depression, according to a pilot clinical trial published in the Journal of the American Geriatrics Society. Researchers found that patients taking Lactobacillus helveticus and Bifidobacterium longum alongside standard antidepressants experienced greater improvements in mood and anxiety symptoms than those taking a placebo, alongside measurable increases in brain-derived neurotrophic factor (BDNF).
How do probiotics affect the brain-gut connection?
The human gut microbiome communicates with the brain through the gut-brain axis, a complex biochemical signaling pathway. According to the study, researchers believe the probiotic strains successfully altered the gut bacteria composition, which in turn influenced systemic biological markers. Participants who received the probiotics showed higher levels of BDNF, a protein essential for the survival and growth of neurons. This finding is significant because low BDNF levels are frequently linked to the pathophysiology of depression and impaired cognitive recovery, as noted by the clinical team from the Indian Council of Medical Research.
The gut is often referred to as the “second brain” because it contains a complex network of neurons and produces approximately 95% of the body’s serotonin, a key neurotransmitter involved in mood regulation.
Comparing probiotic adjunct therapy to standard care
While standard antidepressant medication remains the primary treatment for unipolar depression, it often yields only partial relief for geriatric patients. The pilot study, which followed 58 participants aged 60 and older over 12 weeks, compared the efficacy of adjunct probiotics against standard care alone. While both groups showed substantial improvements—likely due to the consistent clinical oversight—the probiotic group reported statistically lower scores on standardized depression and anxiety scales. Unlike some pharmaceutical interventions, the probiotics were generally well-tolerated, with only minor, transient digestive complaints like bloating or constipation reported by a small subset of the group.
What are the limitations of current probiotic research?
Despite the positive findings, the researchers, led by Dr. Saibal Das and Abhinaba Ghosh, emphasize that these results are preliminary. The study faced a high dropout rate, which can skew long-term data collection. Furthermore, the trial did not find a significant difference between the two groups regarding overall quality of life or cognitive performance. Because the sample size was limited to 58 participants, large-scale, multi-center trials are required to confirm if these biological changes translate into consistent, long-term clinical benefits for the broader aging population.
Future trends in geriatric mental health
The focus of future clinical research is shifting toward “psychobiotics”—probiotics that specifically target mental health conditions. Dr. Saibal Das stated that his team is already planning a larger-scale trial to expand on these findings. The ultimate goal is to develop affordable, accessible, and evidence-based adjunct therapies that can be integrated into existing geriatric care models. This approach aims to address the “lingering symptoms” that often persist even after patients begin standard antidepressant medication, potentially reducing the burden of care for both patients and healthcare systems.
Always consult with a geriatric psychiatrist or primary care physician before adding supplements to a medication regimen, as probiotics can interact with certain treatments or underlying health conditions.
Frequently Asked Questions
- Can probiotics replace antidepressant medication? No. According to the study, probiotics were tested as an adjunct (add-on) to standard treatment, not a replacement.
- Are there side effects to taking these probiotics? The study reported no serious psychiatric side effects, though some participants experienced mild digestive issues like bloating during the first few weeks.
- What is BDNF and why does it matter? BDNF stands for brain-derived neurotrophic factor; it is a protein that supports the growth and function of brain cells and is often lower in individuals suffering from depression.
Have questions about new developments in mental health research? Leave a comment below or subscribe to our newsletter for the latest updates on evidence-based health breakthroughs.
